Sumitomo Bakelite (Taiwan) Co Ltd (台灣住友培科) yesterday broke ground on a new plant in Kaohsiung’s Dafa Industrial Park (大發工業區) to expand production capacity for semiconductor packaging materials.
The company expects the NT$800 million (US$26.05 million) investment to double its production capacity in Taiwan, the Kaohsiung Economic Development Bureau said in a statement.
The company is expected to complete construction of the plant next year, increasing its monthly capacity in Taiwan from 700 tonnes to 1,400 tonnes, the company said.
Photo copied by Ge You-hao, Taipei Times
Sumitomo Bakelite (Taiwan) is a joint venture between Japan’s Sumitomo Bakelite Co Ltd and Taiwan’s Chang Chun Plastics Co Ltd (長春樹脂).
It was founded in 1999, with Sumitomo Bakelite providing 70 percent and Chang Chun Plastics 30 percent of the financing, to produce epoxy molding compounds for semiconductor encapsulation in the region.
Sumitomo Bakelite ranks first in the world in semiconductor packaging materials, with a 40 percent share of the global epoxy molding compounds market, Kaohsiung Economic Development Bureau Director-General Liao Tai-hsiang (廖泰翔) said.
The investment in Kaohsiung reflects the company’s optimism about the long-term outlook for the semiconductor market, Sumitomo Bakelite president Kazuhiko Fujiwara said.
Kaohsiung City Government Deputy Secretary-General Wang Chi-chuan (王啟川), Chang Chun Plastics president Chen Hou-fu (陳厚福) and Chang Wah Electromaterials Inc (長華電材) chairman Canon Huang (黃嘉能) attended the groundbreaking ceremony, along with other business representatives.
Wang praised Sumitomo Bakelite’s presence in the city over the past 24 years, saying that he expected the new investment to drive an industrial transformation in Kaohsiung — from petrochemicals to semiconductors — and bring more employment opportunities.
Companies including Taiwan Semiconductor Manufacturing Co (台積電), Win Semiconductors Corp (穩懋半導體), Winbond Electronics Corp (華邦電子) and Merck Group have over the past two years invested in Kaohsiung, helping establish a semiconductor corridor in the city, he said.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS